Clinical Trial Update: SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction [NA]

View source ↗

Summary

The trial evaluating the SLlt Stent II Lacrimal Stent for nasolacrimal duct obstruction has been terminated, with results posted on February 25, 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolacrimal Duct Obstruction

Snippet

Sponsor: Thomas Gardner | Conditions: Epiphora, Dacryocystorhinostomy | NA | Status: TERMINATED | Results posted: 2026-02-25